Targeting an ultrasound contrast agent to folate receptors on ovarian cancer cells: Feasibility research for ultrasonic molecular imaging of tumor cells

Journal of Ultrasound in Medicine

Volumn 29, Issue 4, 2010, Pages 609-614

  Xing, Wu ^a   Zhigang, Wang ^b   Bing, Hu ^a   Haitao, Ran ^b   Pan, Li ^b   Chuanshan, Xu ^b   Yuanyi, Zheng ^b   Ao, Li ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Folate receptor targeting; Microbubbles; Ovarian cancer; Ultrasound

Indexed keywords

BINS; CELLS; DISEASES; MOLECULAR IMAGING; ORGANIC ACIDS; TUMORS; ULTRASONICS;

BINDING SPECIFICITIES; FOLATE RECEPTOR; MICROBUBBLES; OVARIAN CANCERS; PHYSICAL CHARACTERISTICS; TARGETED MICROBUBBLES; ULTRASONIC MOLECULAR IMAGING; ULTRASOUND CONTRAST AGENT;

CYTOLOGY;

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHATOETHANOLAMINE N (AMINO(POLY(ETHYLENE GLYCOL))); 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHATOETHANOLAMINE-N-(AMINO(POLY(ETHYLENE GLYCOL))); CELL SURFACE RECEPTOR; CONTRAST MEDIUM; DRUG DERIVATIVE; ETHYLENE GLYCOL DERIVATIVE; FOLIC ACID; GLYCEROL;

ARTICLE; CHEMISTRY; CONFOCAL MICROSCOPY; ECHOGRAPHY; FEMALE; HUMAN; METABOLISM; MICROBUBBLE; NONPARAMETRIC TEST; OVARY TUMOR; TUMOR CELL CULTURE;

CONTRAST MEDIA; ETHYLENE GLYCOLS; FEMALE; FOLIC ACID; GLYCEROL; HUMANS; MICROBUBBLES; MICROSCOPY, CONFOCAL; OVARIAN NEOPLASMS; RECEPTORS, CELL SURFACE; STATISTICS, NONPARAMETRIC; TUMOR CELLS, CULTURED;

EID: 77951438979     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2010.29.4.609     Document Type: Article

References (23)

1. Kaufmann BA, Lewis C, Xie A, Mirza-Mohd A, Lindner JR. Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J 2007; 28:2011-2017.
2. Klibanov AL. Ultrasound molecular imaging with targeted microbubble contrast agents. J Nucl Cardiol 2007; 14: 876-884.
3. Klibanov AL. Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging. Med Biol Eng Comput 2009; 47:875-882.
4. Kamaly N, Kalber T, Thanou M, Bell JD, Miller AD. Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjug Chem 2009; 20:648-655.
5. Zhao X, Li H, Lee RJ. Targeted drug delivery via folate receptors. Expert Opin Drug Deliv 2008; 5:309-319.
6. Bhattacharya S, Franz A, Li X, Jasti B. Synthesis of folateconjugated amphiphiles for tumor-targeted drug delivery. J Drug Target 2008;16:780-789.
7. Figini M, Martin F, Ferri R, et al. Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor. Cancer Immunol Immunother 2009; 58:531-546.
8. Larsson SC, Bergkvist L, Wolk A. Folate intake and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Epidemiol Biomarkers Prev 2008; 17:3444-3449.
9. Leamon CP. Folate-targeted drug strategies for the treatment of cancer. Curr Opin Investig Drugs 2008; 9:1277-1286.
10. Saba NF, Wang X, Muller S, et al. Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug. Head Neck 2009; 31:475-481.
11. Deng Y, Wang Y, Cherian C, et al. Synthesis and discovery of high affinity folate receptor-specific glycinamide ribonucleotide formyltransferase inhibitors with antitumor activity. J Med Chem 2008; 51:5052-5063.
12. Ross TL, Honer M, Lam PY, et al. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. Bioconjug Chem 2008; 19:2462-2470.
13. Yamada A, Taniguchi Y, Kawano K, Honda T, Hattori Y, Maitani Y. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. Clin Cancer Res 2008; 14:8161-8168.
14. Zhang L, Hou S, Mao S, Wei D, Song X, Lu Y. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells. Int J Pharm 2004: 287:155-162. (Pubitemid 39487253)
15. Sanna E, Miotti S, Mazzi M, De Santis G, Canevari S, Tomassetti A. Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells. Exp Cell Res 2007; 313:1307-1317.
16. Bottero F, Tomassetti A, Canevari S, Miotti S, Menard S, Colnaghi MI. Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo. Cancer Res 1993; 53:5791-5796.
17. Shmeeda H, Mak L, Tzemach D, Astrahan P, Tarshish M, Gabizon A. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Mol Cancer Ther 2006; 5:818-824.
18. Kawano K, Onose E, Hattori Y, Maitani Y. Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone. Mol Pharm 2009; 6:98-104.
19. Hughes MS, McCarthy JE, Marsh JN, et al. Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging. J Acoust Soc Am 2007; 121:3542-3557.
20. Marsh JN, Partlow KC, Abendschein DR, Scott MJ, Lanza GM, Wickline SA. Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. Ultrasound Med Biol 2007; 33:950-958.
21. Marsh JN, Senpan A, Hu G, et al. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomed 2007; 2:533-543.
22. Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007; 99:1095-1106.
23. Gao Z, Kennedy AM, Christensen DA, Rapoport NY. Drugloaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 2008; 48:260-270.